Clinical Trials Update: April 25, 2008

If you are aged 18 to 50, have moderate-to-severe symptoms of allergy and asthma for at least two years before study entry, and show sensitivity to ragweed, you may qualify for this study. Females of child-bearing potential must have a negative urine pregnancy test at the start of the study, be using birth control, and must notify the study staff if pregnancy status changes.

If you have advanced active cancer for which there is no known curative therapy and have a clinical diagnosis of cancer related pain that is not alleviated with current step III opioid treatment, you may qualify for this study.